Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.

Palmqvist S, Mattsson N, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2016 Apr;139(Pt 4):1226-36. doi: 10.1093/brain/aww015. Epub 2016 Mar 2.

2.

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment.

Shokouhi S, Mckay JW, Baker SL, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2016 Jan 15;8(1):2. doi: 10.1186/s13195-016-0172-3.

3.

Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.

Byun MS, Kim SE, Park J, Yi D, Choe YM, Sohn BK, Choi HJ, Baek H, Han JY, Woo JI, Lee DY; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2015 Nov 30;10(11):e0142756. doi: 10.1371/journal.pone.0142756. eCollection 2015.

4.

Atrial fibrillation, cognitive impairment, and neuroimaging.

Graff-Radford J, Madhavan M, Vemuri P, Rabinstein AA, Cha RH, Mielke MM, Kantarci K, Lowe V, Senjem ML, Gunter JL, Knopman DS, Petersen RC, Jack CR Jr, Roberts RO.

Alzheimers Dement. 2016 Apr;12(4):391-8. doi: 10.1016/j.jalz.2015.08.164. Epub 2015 Oct 23.

PMID:
26607820
5.

Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition.

Schultz SA, Boots EA, Almeida RP, Oh JM, Einerson J, Korcarz CE, Edwards DF, Koscik RL, Dowling MN, Gallagher CL, Bendlin BB, Christian BT, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Hermann BP, Sager MA, Johnson SC, Stein JH, Okonkwo OC.

J Int Neuropsychol Soc. 2015 Nov;21(10):841-50. doi: 10.1017/S1355617715000843.

6.

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.

Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, Lowe V, Senjem ML, Gunter JL, Reyes D, Machulda MM, Roberts R, Petersen RC.

Brain. 2015 Dec;138(Pt 12):3747-59. doi: 10.1093/brain/awv283. Epub 2015 Sep 30.

7.

Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort.

Li J, Zhang Q, Chen F, Yan J, Kim S, Wang L, Feng W, Saykin AJ, Liang H, Shen L.

Biomed Res Int. 2015;2015:647389. doi: 10.1155/2015/647389. Epub 2015 Sep 3.

8.

Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.

Coutinho AM, Porto FH, Duran FL, Prando S, Ono CR, Feitosa EA, Spíndola L, de Oliveira MO, do Vale PH, Gomes HR, Nitrini R, Brucki SM, Buchpiguel CA.

Alzheimers Res Ther. 2015 Sep 15;7(1):58. doi: 10.1186/s13195-015-0143-0.

9.

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.

Palmqvist S, Zetterberg H, Mattsson N, Johansson P; Alzheimer's Disease Neuroimaging Initiative, Minthon L, Blennow K, Olsson M, Hansson O; Swedish BioFINDER Study Group.

Neurology. 2015 Oct 6;85(14):1240-9. doi: 10.1212/WNL.0000000000001991. Epub 2015 Sep 9.

10.

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's Disease.

Paquet C, Dumurgier J, Hugon J.

Front Neurol. 2015 Aug 4;6:168. doi: 10.3389/fneur.2015.00168. eCollection 2015. Review.

11.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005. Review.

PMID:
26194320
12.

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD.

Schindler SE, Fagan AM.

Front Neurol. 2015 Jun 29;6:142. doi: 10.3389/fneur.2015.00142. eCollection 2015. Review.

13.

Stroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes.

Hohman TJ, Samuels LR, Liu D, Gifford KA, Mukherjee S, Benson EM, Abel T, Ruberg FL, Jefferson AL; Alzheimer's Neuroimaging Initiative.

Neurobiol Aging. 2015 Sep;36(9):2501-8. doi: 10.1016/j.neurobiolaging.2015.05.021. Epub 2015 Jun 6.

PMID:
26119224
14.

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment.

Martínez-Torteya A, Treviño V, Tamez-Peña JG.

Biomed Res Int. 2015;2015:961314. doi: 10.1155/2015/961314. Epub 2015 May 28.

15.

Cerebral perfusion in the predementia stages of Alzheimer's disease.

Binnewijzend MA, Benedictus MR, Kuijer JP, van der Flier WM, Teunissen CE, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F.

Eur Radiol. 2016 Feb;26(2):506-14. doi: 10.1007/s00330-015-3834-9. Epub 2015 Jun 5.

16.

Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.

Papp KV, Amariglio RE, Mormino EC, Hedden T, Dekhytar M, Johnson KA, Sperling RA, Rentz DM.

Neuropsychologia. 2015 Jul;73:169-75. doi: 10.1016/j.neuropsychologia.2015.04.034. Epub 2015 May 19.

PMID:
26002757
17.

The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.

Hohman TJ, Bell SP, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Neurol. 2015 May;72(5):520-9. doi: 10.1001/jamaneurol.2014.4761.

18.

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.

Spellman DS, Wildsmith KR, Honigberg LA, Tuefferd M, Baker D, Raghavan N, Nairn AC, Croteau P, Schirm M, Allard R, Lamontagne J, Chelsky D, Hoffmann S, Potter WZ; Alzheimer's Disease Neuroimaging Initiative; Foundation for NIH (FNIH) Biomarkers Consortium CSF Proteomics Project Team.

Proteomics Clin Appl. 2015 Aug;9(7-8):715-31. doi: 10.1002/prca.201400178. Epub 2015 Apr 24.

PMID:
25676562
19.

Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.

Reitz C.

Expert Rev Mol Diagn. 2015 Mar;15(3):339-48. doi: 10.1586/14737159.2015.1002469. Epub 2015 Jan 29. Review.

20.

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.

Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2015 Feb 3;84(5):508-15. doi: 10.1212/WNL.0000000000001209. Epub 2015 Jan 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk